Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292057 (3-(7-Chloro-1H-indazol-5-yl)-2-cyclobutyl-5-(trifl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet  | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0200 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292056 (2-Cyclobutyl-3-(7-methyl-1H-indazol-5-yl)-5-(trifl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0200 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292055 (7-Chloro-5-(2-cyclobutyl-5-(trifluoromethyl)-2H-py...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0320 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292054 (5-(2-Cyclobutyl-5-(trifluoromethyl)-2H-pyrazolo[4,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292053 (3-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-5-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0630 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292061 (5-(Difluoromethyl)-2-isopropyl-3-(7-methyl-1H-inda...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292037 (2-Cyclopentyl-3-(7-methyl-1H-indazol-5-yl)-5-(trif...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.126 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292065 (5,7-Bis(difluoromethyl)-2-isopropyl-3-(7-methyl-1H...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.158 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292051 (7-Chloro-5-(2-isopropyl-5-(trifluoromethyl)-2H-pyr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292052 (2-Isopropyl-3-(7-methyl-1H-indazol-5-yl)-5-(triflu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.251 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292045 (3-(7-Chloro-1H-indazol-5-yl)-2-methyl-5-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.316 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292062 (7-Chloro-5-(5-(difluoromethyl)-2-isopropyl-2H-pyra...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292049 (3-(7-Chloro-1H-indazol-5-yl)-2-ethyl-5-(trifluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292050 (5-(2-Isopropyl-5-(trifluoromethyl)-2H-pyrazolo[4,3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.398 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292041 (2-Cyclobutyl-3-(1H-indazol-5-yl)-5-(trifluoromethy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.631 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292059 (2-(Difluoromethyl)-3-(7-methyl-1H-indazol-5-yl)-5-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.631 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292060 (3-(7-Chloro-1H-indazol-5-yl)-2-(difluoromethyl)-5-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.631 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292048 (2-Ethyl-3-(7-methyl-1H-indazol-5-yl)-5-(trifluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.794 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292032 (5-[2-(Difluoromethyl)-5-(trifluoromethyl)pyrazolo[...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292044 (2-Methyl-3-(7-methyl-1H-indazol-5-yl)-5-(trifluoro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292038 (5-(2-Phenyl-5-(trifluoromethyl)-2H-pyrazolo[4,3-b]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.58 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292058 (7-Chloro-5-(2-(difluoromethyl)-5-(trifluoromethyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.51 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292047 (7-Chloro-5-(2-ethyl-5-(trifluoromethyl)-2H-pyrazol...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.51 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292040 (3-(1H-Indazol-5-yl)-2-phenyl-5-(trifluoromethyl)-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.16 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292046 (5-(2-Ethyl-5-(trifluoromethyl)-2H-pyrazolo[4,3-b]p...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.01 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292039 (5-(2-Phenyl-5-(trifluoromethyl)-2H-pyrazolo[4,3-b]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.31 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292031 (7-Methyl-5-(2-methyl-5-(trifluoromethyl)-2H-pyrazo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12.6 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292036 (5-(2-Cyclopentyl-5-(trifluoromethyl)-2H-pyrazolo[4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15.8 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292034 (5-(2-Isopropyl-5-(trifluoromethyl)-2H-pyrazolo[4,3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 25.1 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292064 (3-(7-Chloro-1H-indazol-5-yl)-2-isopropyl-pyrazolo[...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 63.1 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292033 (5-(2-Ethyl-5-(trifluoromethyl)-2H-pyrazolo[4,3-b]p...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292063 (7-(Difluoromethyl)-2-isopropyl-3-(7-methyl-1H-inda...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 126 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292043 (3-(1H-Indazol-5-yl)-2-(pyridin-2-yl)-5-(trifluorom...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 126 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292035 (5-(2-(Cyclobutylmethyl)-5-(trifluoromethyl)-2H-pyr...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 126 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292030 (5-(2-Methyl-5-(trifluoromethyl)-2H-pyrazolo[4,3-b]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 316 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Voltage-dependent calcium channel gamma-2 subunit (Homo sapiens (Human)) | BDBM292042 (3-(1H-Indazol-5-yl)-2-(2-methoxyethyl)-5-(trifluor...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 794 | n/a | n/a | n/a | n/a | 7.4 | n/a |
Janssen Pharmaceutica NV US Patent | Assay Description Cell expressing the GRIA1o-CACNG8 fusion construct were grown in a monolayer in 96- or 384-well microtiter plates. They were washed with assay buffer... | US Patent US10100045 (2018) BindingDB Entry DOI: 10.7270/Q2MW2K56 | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
